Detection of Evolved High-Redshift Galaxies in Deep NICMOS/VLT Images

A substantial population of high redshift early-type galaxies is detected in very deep UBVRIJHK images towards the HDF-South. Four elliptical profile galaxies are identified in the redshift range z=1-2, all with very red SEDs, implying ages of >2 Gyrs for standard passive evolution. We also find later type IR-luminous galaxies at similarly high redshift, (10 objects with z>1, H1 Gyr. The number and luminosity-densities of these galaxies are comparable with the local E/SO-Sbc populations for \Omega_m>0.2, and in the absence of a significant cosmological constant, we infer that the major fraction of luminous Hubble-sequence galaxies have evolved little since z~2. A highly complete photometric redshift distribution is constructed to H=25 (69 galaxies) showing a broad spread of redshift, peaking at z~1.5, in reasonable agreement with some analyses of the HDF. Five `dropout' galaxies are detected at z~3.8, which are compact in the IR, ~0.5 kpc/h at rest 3500\AA. No example of a blue IR luminous elliptical is found, restricting the star-formation epoch of ellipticals to z>10 for a standard IMF and modest extinction.Comment: 7 pages, 3 figures, accepted for publication in Astrophysical Journal Letters, discussion of clustering added, color image available at http://astro.berkeley.edu/~tjb/nic3.htm

VLT/XSHOOTER and Subaru/MOIRCS spectroscopy of HUDF.YD3: no evidence for Lyman emission at z = 8.55

We present spectroscopic observations with VLT/XSHOOTER and Subaru/MOIRCS of a relatively bright Y-band drop-out galaxy in the Hubble Ultra Deep Field (HUDF), first selected by Bunker et al., McLure et al. and Bouwens et al. to be a likely z ≈ 8–9 galaxy on the basis of its colours in the Hubble Space Telescope (HST) Advanced Camera for Surveys and Wide Field Camera 3 images. This galaxy, HUDF.YD3 (also known as UDFy-38135539), has been targetted for VLT/SINFONI integral field spectroscopy by Lehnert et al., who published a candidate Lyman α emission line at z = 8.55 from this source. In our independent spectroscopy using two different infrared spectrographs (5 h with VLT/XSHOOTER and 11 h with Subaru/MOIRCS), we are unable to reproduce this line. We do not detect any emission line at the spectral and spatial location reported in Lehnert et al., despite the expected signal in our combined MOIRCS and XSHOOTER data being 5σ. The line emission also seems to be ruled out by the faintness of this object in recently extremely deep F105W (Y band) HST/WFC 3 imaging from HUDF12; the line would fall within this filter and such a galaxy should have been detected at YAB = 28.6 mag (∼20σ) rather than the marginal YAB ≈ 30 mag observed in the Y-band image, >3 times fainter than would be expected if the emission line was real. Hence, it appears highly unlikely that the reported Lyman α line emission at z > 8 is real, meaning that the highest redshift sources for which Lyman α emission has been seen are at z = 6.9-7.2. It is conceivable that Lyman α does not escape galaxies at higher redshifts, where the Gunn–Peterson absorption renders the Universe optically thick to this line. However, deeper spectroscopy on a larger sample of candidate z > 7 galaxies will be needed to test this

A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report

<p>Abstract</p> <p>Background</p> <p>Bupropion is approved for the treatment of mood disorders and as an adjuvant medication for smoking cessation. Bupropion is generally well tolerated and considered safe. Two randomized controlled trials of bupropion therapy for smoking cessation did not report any hepatic adverse events. However, there are three reports of severe but non-fatal bupropion hepatotoxicity published in the literature.</p> <p>Case Presentation</p> <p>We present the case of a 55-year old man who presented with jaundice and severe hepatic injury approximately 6 months after starting bupropion for smoking cessation. Laboratory evaluation demonstrated a mixed picture of hepatocellular injury and cholestasis. Liver biopsy demonstrated findings consistent with severe hepatotoxic injury due to drug induced liver injury. Laboratory testing was also notable for positive autoimmune markers. The patient initially had clinical improvement with steroid therapy but eventually died of infectious complications.</p> <p>Conclusion</p> <p>This report represents the first fatal report of bupropion related hepatotoxicity and the second case of bupropion related liver injury demonstrating autoimmune features. The common use of this medication for multiple indications makes it important for physicians to consider this medication as an etiologic agent in patients with otherwise unexplained hepatocellular jaundice.</p

History of Galaxy Interactions and their Impact on Star Formation over the Last 7 Gyr from GEMS

We perform a comprehensive estimate of the frequency of galaxy mergers and their impact on star formation over z~0.24--0.80 (lookback time T_b~3--7 Gyr) using 3698 (M*>=1e9 Msun) galaxies with GEMS HST, COMBO-17, and Spitzer data. Our results are: (1) Among 790 high mass (M*>=2.5e10 Msun) galaxies, the visually-based merger fraction over z~0.24--0.80, ranges from 9%+-5% to 8%+-2%. Lower limits on the major and minor merger fractions over this interval range from 1.1% to 3.5%, and 3.6% to 7.5%, respectively. This is the first approximate empirical estimate of the frequency of minor mergers at z<1. For a visibility timescale of ~0.5 Gyr, it follows that over T_b~3--7 Gyr, ~68% of high mass systems have undergone a merger of mass ratio >1/10, with ~16%, 45%, and 7% of these corresponding respectively to major, minor, and ambiguous `major or minor' mergers. The mean merger rate is a few x 1e-4 Gyr-1 Mpc-3. (2) We compare the empirical merger fraction and rate for high mass galaxies to a suite of Lambda CDM-based models: halo occupation distribution models, semi-analytic models, and hydrodynamic SPH simulations. We find qualitative agreement between observations and models such that the (major+minor) merger fraction or rate from different models bracket the observations, and show a factor of five dispersion. Near-future improvements can now start to rule out certain merger scenarios. (3) Among ~3698 M*>=1e9 Msun galaxies, we find that the mean SFR of visibly merging systems is only modestly enhanced compared to non-interacting galaxies over z~0.24--0.80. Visibly merging systems only account for less than 30% of the cosmic SFR density over T_b~3--7 Gyr. This suggests that the behavior of the cosmic SFR density over the last 7 Gyr is predominantly shaped by non-interacting galaxies.Comment: Accepted for Publication in the Astrophysical Journal. 17 pages of text, 21 figures, 3 tables. Uses emulateapj5.st

Stratification of Outcomes After Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons

ObjectivesThe goal of this study was to examine the impact of reasons for surgical inoperability on outcomes in patients undergoing transcatheter aortic valve replacement (TAVR).BackgroundPatients with severe aortic stenosis may be deemed inoperable due to technical or clinical reasons. The relative impact of each designation on early and late outcomes after TAVR is unclear.MethodsPatients were studied from the inoperable arm (cohort B) of the randomized PARTNER (Placement of Aortic Transcatheter Valve) trial and the nonrandomized continued access registry. Patients were classified according to whether they were classified as technically inoperable (TI) or clinically inoperable (CLI). Reasons for TI included porcelain aorta, previous mediastinal radiation, chest wall deformity, and potential for injury to previous bypass graft on sternal re-entry. Reasons for CLI were systemic factors that were deemed to make survival unlikely.ResultsOf the 369 patients, 23.0% were considered inoperable for technical reasons alone; the remaining were judged to be CLI. For TI, the most common cause was a porcelain aorta (42%); for CLI, it was multiple comorbidities (48%) and frailty (31%). Quality of life and 2-year mortality were significantly better among TI patients compared with CLI patients (mortality 23.3% vs. 43.8%; p < 0.001). Nonetheless, TAVR led to substantial survival benefits compared with standard therapy in both inoperable cohorts.ConclusionsPatients undergoing TAVR based solely on TI have better survival and quality of life improvements than those who are inoperable due to clinical comorbidities. Both TI and CLI TAVR have significant survival benefit in the context of standard therapy. (THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894

Military deployment, masculinity and trauma : reviewing the connections

This article reviews the literature on deployment trauma and examines the limitations of conventional understandings of trauma as they relate to veterans’ experiences. It suggests that the failure to take into account social influences and social relationships limits the usefulness of conventional approaches to trauma. The article considers the role that masculinity plays in male veterans’ experience of and sense making about trauma. It is suggested that while formal recognition of posttraumatic stress disorder in the DSM has provided a helpful language for veterans, it is an incomplete response. A new model of masculinity that better enables the male veteran to speak about trauma and to reconnect with others has implications for counselling practice with veterans

A population of weak metal-line absorbers surrounding the Milky Way

We report on the detection of a population of weak metal-line absorbers in the halo or nearby intergalactic environment of the Milky Way. Using high-resolution ultraviolet absorption-line spectra of bright QSOs obtained with the Space Telescope Imaging Spectrograph (STIS), along six sight lines we have observed unsaturated, narrow absorption in OI and SiII together with mildly saturated CII absorption at high radial velocities (|v_LSR|=100-320 km/s). The measured OI column densities are small, implying that these structures represent Lyman-Limit Systems and sub-Lyman-Limit System with HI column densities < 3x10^18 cm^-2, thus below the detection limits of current 21cm all-sky surveys of high-velocity clouds (HVCs). The absorbers apparently are not directly associated with any of the large high-column density HVC complexes, but rather represent isolated, partly neutral gas clumps embedded in a more tenuous, ionized gaseous medium situated in the halo or nearby intergalactic environment of the Galaxy. We speculate that this absorber population represents the local analog of weak MgII systems that are commonly observed in the circumgalactic environment of low- and high-redshift galaxies.Comment: 45 pages, 7 figures, accepted for publication in Ap

The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study

BACKGROUND: Steatosis is occasionally reported during screening ultrasonography in patients with hepatitis C virus (HCV). We conducted a retrospective observational study to assess the factors associated with steatosis on ultrasonography and the relationship between steatosis on ultrasound versus biopsy in patients infected with HCV in a clinical setting. Our hypothesis was ultrasonography would perform poorly for the detection of steatosis outside of the context of a controlled study, primarily due to false-positive results caused by hepatic fibrosis and inflammation. METHODS: A retrospective review of ultrasound reports was conducted on patients infected with HCV in a tertiary care gastroenterology clinic. Reports were reviewed for the specific documentation of the presence of steatosis. Baseline clinical and histologic parameters were recorded, and compared for patients with vs. without steatosis. Multiple logistic regression analysis was performed on these baseline variables. Liver biopsies were reviewed by two pathologists, and graded for steatosis. Steatosis on biopsy was compared to steatosis on ultrasound report, and the performance characteristics of ultrasonography were calculated, using biopsy as the gold standard. RESULTS: Ultrasound reports were available on 164 patients. Patients with steatosis on ultrasound had a higher incidence of the following parameters compared to patients without steatosis: diabetes (12/49 [24%] vs. 7/115 [6%], p < 0.001), fibrosis stage >2 (15/48 [31%] vs. 16/110 [15%], p = 0.02), histologic grade >2 (19/48 [40%] vs. 17/103 [17%], p = 0.002), and ALT (129.5 ± 89.0 IU/L vs. 94.3 ± 87.0 IU/L, p = 0.01). Histologic grade was the only factor independently associated with steatosis with multivariate analysis. When compared to the histologic diagnosis of steatosis (n = 122), ultrasonography had a substantial number of false-positive and false-negative results. In patients with a normal ultrasound, 8/82 (10%) had >30% steatosis on biopsy. Among patients with steatosis reported on ultrasound, only 12/40 (30%) had >30% steatosis on biopsy review. CONCLUSION: Steatosis on ultrasound is associated with markers of inflammation and fibrosis in HCV-infected patients, but does not consistently correlate with steatosis on biopsy outside of the context of a controlled study. Clinicians should be skeptical of the definitive diagnosis of steatosis on hepatic ultrasonography

On the buildup of massive early-type galaxies at z<~1. I- Reconciling their hierarchical assembly with mass-downsizing

Several studies have tried to ascertain whether or not the increase in abundance of the early-type galaxies (E-S0a's) with time is mainly due to major mergers, reaching opposite conclusions. We have tested it directly through semi-analytical modelling, by studying how the massive early-type galaxies with log(M_*/Msun)>11 at z~0 (mETGs) would have evolved backwards-in-time, under the hypothesis that each major merger gives place to an early-type galaxy. The study was carried out just considering the major mergers strictly reported by observations at each redshift, and assuming that gas-rich major mergers experience transitory phases of dust-reddened, star-forming galaxies (DSFs). The model is able to reproduce the observed evolution of the galaxy LFs at z<~1, simultaneously for different rest-frame bands (B, I, and K) and for different selection criteria on color and morphology. It also provides a framework in which apparently-contradictory results on the recent evolution of the luminosity function (LF) of massive, red galaxies can be reconciled, just considering that observational samples of red galaxies can be significantly contaminated by DSFs. The model proves that it is feasible to build up ~50-60% of the present-day mETG population at z<~1 and to reproduce the observational excess by a factor of ~4-5 of late-type galaxies at 0.8<z<1 through the coordinated action of wet, mixed, and dry major mergers, fulfilling global trends that are in general agreement with mass-downsizing. The bulk of this assembly takes place during ~1 Gyr elapsed at 0.8<z<1. The model suggests that major mergers have been the main driver for the observational migration of mass from the massive-end of the blue galaxy cloud to that of the red sequence in the last ~8 Gyr.(Abridged)Comment: Accepted for publication in Astronomy & Astrophysics; 21 pages, 8 figures. Minor corrections included, shortened title. Results and conclusions unchange

Novel Protein Kinase Signaling Systems Regulating Lifespan Identified by Small Molecule Library Screening Using Drosophila

Protein kinase signaling cascades control most aspects of cellular function. The ATP binding domains of signaling protein kinases are the targets of most available inhibitors. These domains are highly conserved from mammals to flies. Herein we describe screening of a library of small molecule inhibitors of protein kinases for their ability to increase Drosophila lifespan. We developed an assay system which allowed screening using the small amounts of materials normally present in commercial chemical libraries. The studies identified 17 inhibitors, the majority of which targeted tyrosine kinases associated with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptors, G-protein coupled receptor (GPCR), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), the insulin and insulin-like growth factor (IGFI) receptors. Comparison of the protein kinase signaling effects of the inhibitors in vitro defined a consensus intracellular signaling profile which included decreased signaling by p38MAPK (p38), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). If confirmed, many of these kinases will be novel additions to the signaling cascades known to regulate metazoan longevity